LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Search

Phibro Animal Health Corp

Închisă

SectorSănătate

51.23 -0.37

Rezumat

Modificarea prețului

24h

Curent

Minim

50.7

Maxim

52.13

Indicatori cheie

By Trading Economics

Venit

932K

27M

Vânzări

10M

374M

P/E

Medie Sector

23.462

121.746

EPS

0.87

Randament dividend

0.9

Marjă de profit

7.344

Angajați

2,475

EBITDA

-12M

50M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

-6.79% downside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.90%

2.26%

Următoarele câștiguri

6 mai 2026

Data viitoare de dividende

25 mar. 2026

Următoarea dată ex-dividende

4 mar. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

403M

2.1B

Deschiderea anterioară

51.6

Închiderea anterioară

51.23

Sentimentul știrilor

By Acuity

45%

55%

138 / 352 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

Phibro Animal Health Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

11 feb. 2026, 23:47 UTC

Acțiuni populare

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

11 feb. 2026, 22:59 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Grab Holdings to Buy U.S.-Based Stash Financial

11 feb. 2026, 23:54 UTC

Câștiguri

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

11 feb. 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

11 feb. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

11 feb. 2026, 23:49 UTC

Câștiguri

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

11 feb. 2026, 23:45 UTC

Câștiguri

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

11 feb. 2026, 23:42 UTC

Câștiguri

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

11 feb. 2026, 23:41 UTC

Câștiguri

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

11 feb. 2026, 23:40 UTC

Câștiguri

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

11 feb. 2026, 23:35 UTC

Market Talk

Gold Falls on Prospects of Long Fed Pause -- Market Talk

11 feb. 2026, 23:18 UTC

Market Talk

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

11 feb. 2026, 23:14 UTC

Market Talk

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

11 feb. 2026, 22:59 UTC

Câștiguri

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

11 feb. 2026, 22:59 UTC

Câștiguri

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

11 feb. 2026, 22:59 UTC

Câștiguri

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

11 feb. 2026, 22:58 UTC

Câștiguri

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

11 feb. 2026, 22:57 UTC

Câștiguri

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

11 feb. 2026, 22:54 UTC

Câștiguri

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

11 feb. 2026, 22:53 UTC

Câștiguri

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

11 feb. 2026, 22:47 UTC

Câștiguri

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 feb. 2026, 22:47 UTC

Câștiguri

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 feb. 2026, 22:23 UTC

Câștiguri

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

11 feb. 2026, 22:22 UTC

Câștiguri

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

11 feb. 2026, 22:22 UTC

Câștiguri

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

11 feb. 2026, 22:19 UTC

Câștiguri

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

11 feb. 2026, 22:18 UTC

Câștiguri

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

11 feb. 2026, 22:18 UTC

Câștiguri

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

11 feb. 2026, 22:18 UTC

Câștiguri

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

11 feb. 2026, 22:16 UTC

Câștiguri

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Comparație

Modificare preț

Phibro Animal Health Corp Așteptări

Obiectiv de preț

By TipRanks

-6.79% jos

Prognoză pe 12 luni

Medie 48.33 USD  -6.79%

Maxim 58 USD

Minim 38 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPhibro Animal Health Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

3 ratings

1

Cumpărare

1

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

17 / N/ASuport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Weak Bearish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

138 / 352 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
help-icon Live chat